- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05080283
Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients. (PINNA)
September 14, 2022 updated by: Cochlear
A Pre-Marketing, Prospective, Single-Site, Open-Label, Within-Subject, Actual-Use, Interventional Study of Acceptance and Performance With Experienced Adult Cochlear Implant Recipients Using the CP1110 Sound Processor Compared With the CP1000 Sound Processor
The clinical study aims to investigate acceptance, actual-use usability and speech performance with a new behind-the-ear sound processor (model number: CP1110) system, compared with the commercially available Nucleus 7 Sound Processor (model: CP1000) system, with particular focus on the acceptance of and satisfaction with a noise reduction feature in the Automatic Scene Classifier 'SCAN'.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The clinical study aims to investigate acceptance, actual-use usability and speech performance with a new behind-the-ear sound processor (model number: CP1110) system, compared with the commercially available Nucleus 7 Sound Processor (model: CP1000) system, with particular focus on the acceptance of and satisfaction with a noise reduction feature in the Automatic Scene Classifier 'SCAN'.
This study will build on the evidence collected in previous Nucleus 7 Sound Processor take home studies and will also aim to confirm the in-booth performance of CP1110 and Nucleus 7 Sound Processors.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2109
- Cochlear Sydney
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 18 years or older.
- Post lingually deafened.
- Implanted with the CI600 Series (CI612, CI632, CI622, CI624), CI500 Series (CI512, CI532, CI522) or Freedom Series (CI24RE(CA), CI24RE(ST), CI422).
- At least 6 months experience with a cochlear implant.
- At least 3 months experience with a Nucleus 7 (CP1000) Sound Processor
- Able to score 30% or more at +15 SNR with CI alone on a sentence in babble test
- Willingness to participate in and to comply with all requirements of the protocol.
- Fluent speaker in English as determined by the investigator
- Willing and able to provide written informed consent
Exclusion Criteria:
- Additional disabilities that would prevent participation in evaluations.
- Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedures.
- Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
- Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
- Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
- Currently participating, or participated in another interventional clinical study/trial in the past 30 days or if less than 30 days, the prior investigation was Cochlear sponsored and determined by the investigator to not impact clinical findings of this investigation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CP1110 Sound Processor System with ForwardFocus On (SCAN)
|
Sound Processor
|
Experimental: CP1110 Sound Processor System with ForwardFocus Off (SCAN)
|
Sound Processor
|
Active Comparator: Nucleus 7 Sound Processor (model: CP1000) system
|
Sound Processor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Speech Reception Thresholds (SRT) assessed in spatially separated speech and noise (S0Nrearhalf).
Time Frame: 6 months
|
Paired difference in dB SRT (AuSTIN) between the CP1110 Sound Processor with ForwardFocus ON (SCAN) and ForwardFocus OFF (SCAN) (65 dB SPL S0Nrearhalf 4TB).
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Speech Reception Thresholds (SRT) assessed in spatially separated speech and noise (S0N3).
Time Frame: 6 months
|
Paired difference in dB SRT (AuSTIN) between the CP1110 Sound Processor with ForwardFocus On (SCAN) and ForwardFocus OFF (SCAN) (65 dB SPL S0N3 Babble).
|
6 months
|
Adult cochlear implant speech perception in quiet with the CP1110 Sound Processor and the Nucleus 7 Sound Processor.
Time Frame: 6 months
|
Paired difference in percentage CNC Words correct in quiet (50 dB) with the CP1110 Sound Processor and Nucleus 7 Sound Processor.
|
6 months
|
Adult cochlear implant subjective hearing performance and sound quality with the CP1110 Sound Processor and Nucleus 7 Sound Processor.
Time Frame: 6 months
|
Paired difference in Global Speech, Spatial and Qualities of Hearing Scale SSQ12 scores after experience with the CP1110 Sound Processor and Nucleus 7 Sound Responses on the SSQ12 have a minimum value of 0 and a maximum of 10, wherein a higher score means a better outcome.
|
6 months
|
To evaluate acceptance and satisfaction of the CP1110 Sound Processor.
Time Frame: 6 months
|
Responses on the 'CP1110 Questionnaire 1' after at least 2 weeks of experience with the CP1110 Sound Processor and 'CP1110 Questionnaire 2' up to 6 months later.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 2, 2021
Primary Completion (Actual)
September 13, 2022
Study Completion (Actual)
September 13, 2022
Study Registration Dates
First Submitted
September 19, 2021
First Submitted That Met QC Criteria
October 13, 2021
First Posted (Actual)
October 15, 2021
Study Record Updates
Last Update Posted (Actual)
September 16, 2022
Last Update Submitted That Met QC Criteria
September 14, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- CLTD5810
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adult Cochlear Implant Recipients
-
CochlearAvaniaCompleted
-
University of ZurichCompletedCochlear Implant RecipientsSwitzerland
-
Hospices Civils de LyonRecruiting
-
Assiut UniversityNot yet recruitingCochlear Implant
-
Mayo ClinicCompletedCochlear ImplantUnited States
-
Vanderbilt University Medical CenterEnrolling by invitation
-
Vanderbilt University Medical CenterNational Institute on Deafness and Other Communication Disorders (NIDCD)WithdrawnCochlear ImplantUnited States
-
Oticon MedicalCompleted
Clinical Trials on CP1110 Sound Processor System
-
CochlearAvaniaCompletedHearing Impairment, SensorineuralAustralia
-
CochlearAvaniaCompleted
-
CochlearAvaniaNot yet recruitingHearing Loss, Conductive | Hearing Loss, Mixed Conductive-SensorineuralAustralia
-
Oticon MedicalSahlgrenska University Hospital, SwedenCompletedConductive Hearing Loss | Mixed Hearing LossSweden
-
Advanced Bionics AGCompletedCochlear Hearing LossGermany
-
Advanced BionicsCompletedOtorhinolaryngologic Diseases | Ear Diseases | Hearing Loss | Hearing DisordersUnited States
-
CochlearCompletedConductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing LossAustralia
-
CochlearWithdrawnHearing LossBelgium, United Kingdom